Antimicrobial resistance and its impact on cancer care

Antimicrobial resistance (AMR) or drug resistance, including antibiotic resistance, is a growing public health issue and needs urgent attention in countries around the world. Due to a variety of factors, people with cancer are particularly vulnerable to AMR, which is threatening the progress being made in cancer care.

COVID-19 and Antimicrobial Resistance: Dual Health Threats

World AMR Awareness Week (WAAW)

Antimicrobial resistance and its impact on cancer care

Antimicrobial resistance (AMR)

The Impact of Antimicrobial Resistance on Cancer Patients

A view on drug resistance in cancer

The Impact of Antimicrobial Resistance on Cancer Patients

Five reasons to care about antimicrobial resistance (AMR) - Consilium

Antimicrobial resistance (AMR) and its impact on cancer care

Antimicrobial resistance and its impact on cancer care

Looking back to look forward: 90 years of unity towards winning the fight against cancer

Antimicrobial Resistance Fighter Coalition on X: Facing cancer is tough, and antimicrobial resistance (AMR) adds to the challenge. #AMR affects infection treatment in vulnerable cancer patients. Join us in tackling this issue.